Chris Sale has long been one of MLB's most dominant southpaws, a strikeout machine with a unique, whip-like delivery. His high-octane fastball and devastating slider made him a cornerstone for the Boston Red Sox and a key piece in their 2018 World Series run. Following that championship glory, the Red Sox locked him up with a massive extension, hoping to secure his elite talent for years to come and solidify his place as a franchise icon.
Breaking Down Sale's Landmark Deal
Sale officially inked his lucrative deal with the Boston Red Sox on March 23, 2019. This was a five-year contract worth $145 million, running through the 2024 season, with a club option for 2025 that could have brought the total value to $160 million over six years. The deal solidified Sale's status as one of baseball's highest-paid pitchers at the time, reflecting the immense value he brought to the mound. However, injuries largely plagued his time in Boston post-signing, limiting his availability and effectiveness. Fast forward to December 2023, and Sale was traded to the Atlanta Braves, who promptly exercised his $16 million club option for the 2024 season, ensuring his return to the mound in a new uniform.
This significant contract, and its subsequent pickup by the Braves, speaks volumes about the enduring belief in Chris Sale's talent, despite a challenging few years marked by Tommy John surgery and other physical setbacks. For Sale, it represented financial security and a long-term commitment from a top-tier organization, initially the Red Sox, and now the Braves. While it placed immense pressure on him to perform at an elite level, a challenge amplified by his injury woes, heading into 2024 with the Braves, the contract means he has another prime opportunity to re-establish himself as an ace on a contending team. It's a testament to his potential and a fresh start that could define the latter part of his illustrious career.
Trade on Every Game with Kalshi
Click Here to sign up to Kalshi — Free $10 when you sign up using our link or use code: ONTAPSEA. The only federally regulated prediction market in the US. Trade on real sports outcomes. Available in all 50 states.